Dual isotope study of iodine-125 and indium-111-labeled antibody in athymic mice
- PMID: 2738666
Dual isotope study of iodine-125 and indium-111-labeled antibody in athymic mice
Abstract
Monoclonal antibody B72.3 was coupled to a benzylisothiocyanate derivative of diethylenetriaminepentaacetic acid (DTPA). The maximum substitution achievable without loss of immunoreactivity was three DTPA groups per immunoglobulin molecule. The resulting conjugate was labeled with 111In by brief incubation with 111InCl3, giving a mean radiochemical yield of 111In-labeled antibody of 96%. The [111In]B72.3 preparation was mixed with an [125I] B72.3 preparation, obtained by the chloramine-T method, and the mixture administered to athymic mice bearing subcutaneous LS174T colon carcinoma xenografts. There were no significant differences (p greater than 0.1) in the biodistributions of the two labels at 1, 2, 5, and 7 days postinjection. These results are contrasted with prior studies showing elevated levels of 111In in liver, spleen, and kidneys using B72.3-DTPA conjugates prepared via the bicyclic anhydride. It is concluded that protein cross-linking and/or the formation of unstable chelate sites in anhydride coupled conjugates underlie these disparities.
Similar articles
-
New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.J Nucl Med. 1987 May;28(5):861-70. J Nucl Med. 1987. PMID: 3106595
-
Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.J Nucl Med. 1989 May;30(5):672-82. J Nucl Med. 1989. PMID: 2785585
-
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.Br J Cancer. 1994 Jul;70(1):35-41. doi: 10.1038/bjc.1994.246. Br J Cancer. 1994. PMID: 8018538 Free PMC article.
-
Labeling of monoclonal antibodies with radionuclides.Semin Nucl Med. 1989 Jul;19(3):187-201. doi: 10.1016/s0001-2998(89)80013-3. Semin Nucl Med. 1989. PMID: 2503873 Review.
-
Radiolabeling antibodies via the cyclic anhydride of DTPA--experiences of 5 years.Cancer Treat Res. 1990;51:173-81. doi: 10.1007/978-1-4613-1497-4_8. Cancer Treat Res. 1990. PMID: 1977443 Review. No abstract available.
Cited by
-
Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates.Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12181-6. doi: 10.1073/pnas.1406233111. Epub 2014 Aug 4. Proc Natl Acad Sci U S A. 2014. PMID: 25092316 Free PMC article.
-
Immunoscintigraphy for cancer detection: "a thousand ills require a thousand cures".J Cancer Res Clin Oncol. 1992;118(1):1-15. doi: 10.1007/BF01192305. J Cancer Res Clin Oncol. 1992. PMID: 1729256 Free PMC article. Review. No abstract available.
-
A novel approach to quantitate biodistribution and transduction of adeno-associated virus gene therapy using radiolabeled AAV vectors in mice.Mol Ther Methods Clin Dev. 2024 Aug 19;32(3):101326. doi: 10.1016/j.omtm.2024.101326. eCollection 2024 Sep 12. Mol Ther Methods Clin Dev. 2024. PMID: 39286334 Free PMC article.
-
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Pharm Res. 2011 Jul;28(7):1500-19. doi: 10.1007/s11095-010-0339-8. Epub 2010 Dec 23. Pharm Res. 2011. PMID: 21181549 Review.
-
Determining recombinant AAV capsid extracellular and intracellular biodistribution by dual radioisotope labeling.Mol Ther Methods Clin Dev. 2024 Nov 21;32(4):101373. doi: 10.1016/j.omtm.2024.101373. eCollection 2024 Dec 12. Mol Ther Methods Clin Dev. 2024. PMID: 39649706 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources